The Chicago Entrepreneur

Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up

Alzheimer’s drug Leqembi brought in in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.

Previous post Kering shares sink 9% after profit warning on declining Gucci sales
Next post Biogen first-quarter profit tops estimates as Alzheimer’s drug uptake improves